Literature DB >> 21963852

Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy.

L Galluzzi, O Kepp, G Kroemer.   

Abstract

Chemo- and radio-therapeutic regimens frequently kill cancer cells by inducing apoptosis, a cell-death subroutine that involves the activation of a particular class of proteases called caspases. In a recent issue of Nature Medicine, Huang et al. (2011) show that caspase activation in dying tumor cells causes the release of soluble lipid messengers, notably prostaglandin E(2), that stimulate tumor cell proliferation. In this short review, we will discuss the clinical and therapeutic implications of these findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963852     DOI: 10.1038/onc.2011.459

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.

Authors:  Jin Cheng; Ling Tian; Jingjing Ma; Yanping Gong; Zhengxiang Zhang; Zhiwei Chen; Bing Xu; Hui Xiong; Chuanyuan Li; Qian Huang
Journal:  Mol Oncol       Date:  2014-08-07       Impact factor: 6.603

2.  Effect on proliferation and apoptosis of retinoblastoma cell by RNA inhibiting high mobility group protein box-1 expression.

Authors:  Li-Lun Wang; Yan-Qin Feng; Yu-Hong Cheng
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

Review 3.  Drugging cancer metabolism: Expectations vs. reality.

Authors:  David C Montrose; Lorenzo Galluzzi
Journal:  Int Rev Cell Mol Biol       Date:  2019-07-29       Impact factor: 6.813

4.  Saikosaponin-D Reduces H2O2-Induced PC12 Cell Apoptosis by Removing ROS and Blocking MAPK-Dependent Oxidative Damage.

Authors:  Xuemei Lin; Songdi Wu; Qing Wang; Yaling Shi; Guozheng Liu; Jin Zhi; Fang Wang
Journal:  Cell Mol Neurobiol       Date:  2016-03-09       Impact factor: 5.046

5.  Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.

Authors:  Xianzhe Liu; Yan Gao; Jacson Shen; Wen Yang; Edwin Choy; Henry Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  Mol Cancer Ther       Date:  2016-05-20       Impact factor: 6.261

6.  Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.

Authors:  Dong Liu; Xianjun Feng; Xinjun Wu; Zhanguo Li; Wanling Wang; Yipeng Tao; Yonghua Xia
Journal:  Tumour Biol       Date:  2013-06-30

7.  Caspase-3 cleaved p65 fragment dampens NF-κB-mediated anti-apoptotic transcription by interfering with the p65/RPS3 interaction.

Authors:  Eric M Wier; Kai Fu; Andrea Hodgson; Xin Sun; Fengyi Wan
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

8.  Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer.

Authors:  Jin-Ping Wang; Ji-Ping Yan; Jing Xu; Ting-Hui Yin; Rong-Qin Zheng; Wei Wang
Journal:  Cancer Manag Res       Date:  2019-07-16       Impact factor: 3.989

9.  CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

Authors:  Jian Zheng; Xiaobai Liu; Ping Wang; Yixue Xue; Jun Ma; Chengbin Qu; Yunhui Liu
Journal:  Mol Ther       Date:  2016-04-08       Impact factor: 11.454

10.  Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.

Authors:  Carlos D Gamarra-Luques; Alicia A Goyeneche; Maria B Hapon; Carlos M Telleria
Journal:  BMC Cancer       Date:  2012-06-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.